Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.86−0.06 (-0.73%)
Close on Nov 17, 2026Market cap $3.00BP/E –Yield –
Telix Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Telix Pharmaceuticals's enterprise value was $3.55B on Nov 11, 2026, against $3.35B a year earlier. Over the last 2 years it ranged from $2.43B to $5.94B, with a median of $3.97B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.55B | +42.1% |
| 2025 | Dec 31, 2025 | $2.50B | -49.1% |
| 2024 | Dec 31, 2024 | $4.91B | – |
See a number that looks wrong?